Until the FDA issues specific guidance defining the comparability standard for autologous C&G therapies (a process that will require substantial scientific input from industry, academia, and patient advocacy groups), the BPCIA pathway for C&G therapy biosimilars remains operationally undefined
Known for its remarkable healing properties, it supports various systems in the body, including muscles, joints, ligaments, and even the gastrointestinal tract
It has been selected for its ability to recognize GPX1 in immunohistochemical staining and western blotting
Pediatric If laboratory tests reveal that a child has an amino acid imbalance requiring treatment, a healthcare provider may recommend a complete amino acid supplement containing carnitine
Suggested Clinical-Style Protocol (Minimum 6 Sessions)